Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy

Purpose. To determine the immune response after dendritic cell (DC) vaccine and cytokine-induced killer cells (CIK) therapy and assess its associated toxicity, survival benefit, and changes in the quality of life (QOL) of advanced colorectal cancer (CRC) patients. Methods. We recruited 100 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hui, Yang, Xuejing, Li, Jiali, Ren, Yanjie, Zhang, Tianyu, Zhang, Chunze, Zhang, Jintai, Li, Jing, Pang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124766/
https://www.ncbi.nlm.nih.gov/pubmed/25136601
http://dx.doi.org/10.1155/2014/603871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124766/
https://www.ncbi.nlm.nih.gov/pubmed/25136601
http://dx.doi.org/10.1155/2014/603871

Ejemplares similares